TABLE 1.
Basline characteristics of the patients.
| Variable | All patients (n = 731) | Survivor (n = 571) | Non-survivor (n = 160) | P |
| Age(years) | 52.99 ± 12.17 | 52.87 ± 11.91 | 53.41 ± 13.12 | 0.619 |
| BMI(kg/m2) | 25.13 ± 4.63 | 25.21 ± 4.47 | 24.86 ± 5.16 | 0.393 |
| SBP(mmHg) | 145.61 ± 30.30 | 148.18 ± 28.66 | 136.44 ± 34.11 | <0.001 |
| DBP(mmHg) | 81.22 ± 18.52 | 83.14 ± 17.88 | 74.38 ± 19.17 | <0.001 |
| IMA(μ/ml) | 74.66 ± 20.84 | 69.14 ± 14.70 | 94.35 ± 26.84 | <0.001 |
| Hb(g/L) | 125.05 ± 20.98 | 126.04 ± 19.84 | 121.55 ± 24.37 | 0.017 |
| ALT(μ/L) | 20.50 (14.00–36.70) | 19.80 (13.30–34.80) | 23.20 (15.43–56.50) | <0.001 |
| AST(μ/L) | 21.10 (16.00–34.50) | 20.30 (15.60–30.40) | 24.80 (17.78–75.65) | <0.001 |
| ALB(g/L) | 35.62 ± 4.61 | 35.84 ± 4.55 | 34.84 ± 4.76 | 0.016 |
| TB(μmol/L) | 14.60 (9.80–20.40) | 14.50 (9.85–20.20) | 14.70 (9.67–22.05) | 0.982 |
| DB(μmol/L) | 5.30 (3.70–7.80) | 5.30 (3.70–7.55) | 5.40 (3.68–8.30) | 0.313 |
| Cr(μmol/L) | 81.50 (65.50–116.60) | 78.20 (63.90–101.35) | 104.80 (71.15–170.25) | <0.001 |
| cTnT(pg/ml) | 8.94 (4.21–21.07) | 8.11 (4.14–16.41) | 17.04 (4.86–65.45) | <0.001 |
| CK-Mb(μ/L) | 12.90 (8.85–18.15) | 12.70 (9.00–17.30) | 14.70 (8.28–23.83) | <0.001 |
| Gender | 0.259 | |||
| Male | 585 (80.03%) | 462 (80.91%) | 123 (76.88%) | |
| Female | 146 (19.97%) | 109 (19.09%) | 37 (23.12%) | |
| Hypertension | 0.609 | |||
| No | 221 (30.23%) | 170 (29.77%) | 51 (31.87%) | |
| Yes | 510 (69.77%) | 401 (70.23%) | 109 (68.13%) | |
| Diabetes | 0.449 | |||
| No | 702 (96.03%) | 550 (96.32%) | 152 (95.00%) | |
| Yes | 29 (3.97%) | 21 (3.68%) | 8 (5.00%) | |
| Stroke | 0.952 | |||
| No | 703 (96.17%) | 549 (96.15%) | 154 (96.25%) | |
| Yes | 28 (3.83%) | 22 (3.85%) | 6 (3.75%) | |
| Atherosclerosis | 0.469 | |||
| No | 664 (90.83%) | 521 (91.24%) | 143 (89.38%) | |
| Yes | 67 (9.17%) | 50 (8.76%) | 17 (10.62%) | |
| Marfan syndrome | 0.234 | |||
| No | 713 (97.54%) | 559 (97.90%) | 154 (96.25%) | |
| Yes | 18 (2.46%) | 12 (2.10%) | 6 (3.75%) | |
| CRI | <0.001 | |||
| No | 704 (96.31%) | 558 (97.72%) | 146 (91.25%) | |
| Yes | 27 (3.69%) | 13 (2.28%) | 14 (8.75%) | |
| Smoking | 0.027 | |||
| No | 510 (69.77%) | 387 (67.78%) | 123 (76.88%) | |
| Yes | 221 (30.23%) | 184 (32.22%) | 37 (23.12%) | |
| Symptom | <0.001 | |||
| Chest pain | 573 (78.39%) | 446 (78.11%) | 127 (79.38%) | |
| Back pain | 30 (4.10%) | 23 (4.03%) | 7 (4.38%) | |
| Abdominal pain | 49 (6.70%) | 42 (7.36%) | 7 (4.38%) | |
| Syncope | 7 (0.96%) | 1 (0.18%) | 6 (3.75%) | |
| Other | 72 (9.85%) | 59 (10.33%) | 13 (8.12%) | |
| Myocardial ischemia | <0.001 | |||
| No | 666 (91.11%) | 538 (94.22%) | 128 (80.00%) | |
| Yes | 65 (8.89%) | 33 (5.78%) | 32 (20.00%) | |
| Type of AAD (Stanford) | <0.001 | |||
| A | 337 (46.10%) | 204 (35.73%) | 133 (83.12%) | |
| B | 394 (53.90%) | 367 (64.27%) | 27 (16.88%) | |
| Management | <0.001 | |||
| Medical | 215 (29.41%) | 90 (15.76%) | 125 (78.12%) | |
| Endovascular | 310 (42.41%) | 303 (53.06%) | 7 (4.38%) | |
| Surgical | 206 (28.18%) | 178 (31.17%) | 28 (17.50%) |
ALB, albumin; ALT, alanine transaminase; AST, aspartate aminotransferase; BMI, body mass index; CK-Mb, creatine kinase Mb; Cr, creatinine; CRI, chronic renal insufficiency; cTnT, Troponin T; DB, direct bilirubin; DBP, diastole blood pressure; Hb, hemoglobin; IMA, ischemia-modified albumin; SBP, systolic blood pressure; TB, total bilirubin.